The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide
- PMID: 1372891
The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide
Abstract
Deletion of phenylalanine 508 (delta Phe-508) in the cystic fibrosis transmembrane conductance regulator (CFTR) protein causes approximately 70% of all cases of cystic fibrosis. This residue lies in a region of the protein that we have synthesized chemically and shown to bind adenine nucleotides (Thomas, P. J., Shenbagamurthi, P., Ysern, X., and Pedersen, P. L. (1991) Science 251, 555-557). A peptide lacking this critical residue, but otherwise corresponding to this crucial part of the protein, now also has been chemically synthesized and purified. This mutant peptide (P-66) exhibits a significant loss of beta-sheet structure as compared with the wild type peptide (P-67). Furthermore, urea denaturation of peptide structure reveals that P-66 is less stable than P-67. Although under non-denaturing conditions both peptides bind adenine nucleotides with high affinity, the loss of structural stability is reflected in the binding function of the peptides. Thus, P-67, in contrast to P-66, retains a significant capacity for nucleotide binding in 4 M urea. These results suggest a model for impaired delta Phe-508 CFTR function.
Similar articles
-
The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein.J Biol Chem. 1993 Nov 15;268(32):24330-8. J Biol Chem. 1993. PMID: 7693699
-
The cystic fibrosis transmembrane conductance regulator. Nucleotide binding to a synthetic peptide segment from the second predicted nucleotide binding fold.J Biol Chem. 1994 May 20;269(20):14584-8. J Biol Chem. 1994. PMID: 7514174
-
Dysfunction of CFTR bearing the delta F508 mutation.J Cell Sci Suppl. 1993;17:235-9. J Cell Sci Suppl. 1993. PMID: 7511616 Review.
-
Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide.Science. 1991 Feb 1;251(4993):555-7. doi: 10.1126/science.1703660. Science. 1991. PMID: 1703660
-
Altered protein folding may be the molecular basis of most cases of cystic fibrosis.FEBS Lett. 1992 Nov 2;312(1):7-9. doi: 10.1016/0014-5793(92)81399-7. FEBS Lett. 1992. PMID: 1385213 Review.
Cited by
-
Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.Int J Mol Sci. 2020 Jan 10;21(2):452. doi: 10.3390/ijms21020452. Int J Mol Sci. 2020. PMID: 31936842 Free PMC article. Review.
-
Short-term consequences of F508del-CFTR thermal instability on CFTR-dependent transepithelial currents in human airway epithelial cells.Sci Rep. 2019 Sep 24;9(1):13729. doi: 10.1038/s41598-019-50066-7. Sci Rep. 2019. PMID: 31551433 Free PMC article.
-
Complement yourself: Transcomplementation rescues partially folded mutant proteins.Biophys Rev. 2014 Mar 1;6(1):169-180. doi: 10.1007/s12551-014-0137-3. Biophys Rev. 2014. PMID: 24949105 Free PMC article.
-
Development of CFTR Structure.Front Pharmacol. 2012 Sep 6;3:162. doi: 10.3389/fphar.2012.00162. eCollection 2012. Front Pharmacol. 2012. PMID: 22973227 Free PMC article.
-
Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.Cell. 2012 Jan 20;148(1-2):164-74. doi: 10.1016/j.cell.2011.11.023. Cell. 2012. PMID: 22265409 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
